Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/1998
09/30/1998EP0867177A1 Free-flowing dried particles
09/30/1998EP0867175A1 Complexes of gamma-cyclodextrins and retinol or retinol-derivatives and manufacturing process thereof and their use
09/30/1998EP0866874A1 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids
09/30/1998EP0866814A1 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents
09/30/1998EP0866803A1 Transferrin receptor protein of moraxella
09/30/1998EP0866802A1 Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds.
09/30/1998EP0866722A1 Improved formulation for administration of steroid compounds
09/30/1998EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells
09/30/1998EP0866713A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
09/30/1998EP0866709A1 1,2,4-benzotriazine oxides formulations
09/30/1998EP0866690A1 Endoparasiticidal agents
09/30/1998EP0866683A1 Composition and method for treating diseased nails
09/30/1998EP0577646B1 Sustained release drug delivery devices
09/30/1998CN1194651A Modified/chimeric superantigens and their use
09/30/1998CN1194139A Oral medicinal composition containing pyridazinone compound
09/29/1998US5814687 Magnetic particles with polymers
09/29/1998US5814659 Topical analgesic composition
09/29/1998US5814635 Concentrated injection solution of alkali metal salts of reduced folates
09/29/1998US5814632 Immunopotentiating and infection protective agent and production thereof
09/29/1998US5814623 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
09/29/1998US5814621 Drug composition and process for preparing the same
09/29/1998US5814603 Parathyroid hormone peptide with amino acid sequences
09/29/1998US5814464 Nucleic acids encoding TIE-2 ligand-2
09/29/1998US5814341 Carrier and glucan for cosmetics
09/29/1998US5814339 Core of a mixture of the drugs and a carrier of below 20% total weight; migraine headaches
09/29/1998US5814336 Therapeutically active agent, enteric polymer and plasticizer
09/29/1998US5814330 Mucoadhesive emulsions containing cyclodextrin
09/29/1998US5814329 Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
09/29/1998US5814322 Gelled cosmetic and/or dermatological composition which is rich in solvent and which contains hollow particles, and its applications
09/29/1998US5814317 Structural alterations of the EGF receptor gene in human gliomas
09/29/1998US5814307 Synthesis of interleukins for cells
09/29/1998US5814305 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
09/29/1998US5814301 Contrast agents for medical diagnosis of cardiovascular disorders
09/29/1998US5814032 Drug delivery with tape for transdermal delivery and multilayer bandages
09/29/1998CA2118032C Therapeutic conjugates of toxins and drugs
09/24/1998WO1998041641A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
09/24/1998WO1998041591A1 Novel uses of heptafluoropropane
09/24/1998WO1998041562A1 Non-antigenic branched polymer conjugates
09/24/1998WO1998041558A1 Method for gelling aqueous media, use of copolyesters as gelling agents of aqueous media and novel copolyesters for gelling aqueous media
09/24/1998WO1998041547A1 Improvements relating to bran gels
09/24/1998WO1998041540A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
09/24/1998WO1998041535A2 Activation of peptides
09/24/1998WO1998041239A1 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
09/24/1998WO1998041225A1 Pharmaceutical compositions
09/24/1998WO1998041218A1 An aqueous metal bicarbonate solution and method of use
09/24/1998WO1998041208A1 Compositions and methods for reducing ocular hypertension
09/24/1998WO1998041193A1 Preparation of powder agglomerates
09/24/1998WO1998041191A1 Aerosol preparation
09/24/1998WO1998041188A2 Stable particle in liquid formulations
09/24/1998CA2284581A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
09/24/1998CA2283901A1 Pharmaceutical compositions
09/23/1998EP0865789A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine
09/23/1998EP0865787A1 Method of making controlled release compositions
09/23/1998EP0865786A1 Solid topical aqueas composition rersembling a gel to form a film when applied
09/23/1998EP0865463A1 Process for the preparation of porous polyyolefin particles
09/23/1998EP0865298A1 Drug therapy
09/23/1998EP0865292A1 Compositions and methods for the prevention and treatment of oral mucositis
09/23/1998EP0865289A1 Arctium majus compositions
09/23/1998EP0865288A2 Bioartificial devices and cellular matrices therefor
09/23/1998EP0765173A4 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes
09/23/1998EP0700285B1 A drug delivery composition for alpha-adreno receptor blocking agents
09/23/1998EP0695176B1 Solid form of administration of isosorbide 5-mononitrate
09/23/1998EP0684839B1 Process for preparing colloidal aqueous solutions of hardly soluble active substances
09/23/1998EP0621877B1 Esters of pectic and pectinic acid
09/23/1998CN1193965A 10-acyloxy-10,11-dihydrodibenz/b, f/azepine-5-carboxamides useful for treating nervous system disorders
09/23/1998CN1193915A Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
09/23/1998CN1193914A Method of preventing TPO adsorption and stable TPO containing composition
09/23/1998CN1193909A Water activable viscous compositions containing tetracainum
09/23/1998CN1193907A Preparation and methods for the treatment of T cell mediated diseases
09/23/1998CN1193906A Therapeutic effervescent compositions
09/23/1998CN1193901A Refreshing compositions
09/23/1998CN1193893A Stabilisation of flavourants
09/23/1998CN1193510A Oily injection for preventing animals from parasites
09/23/1998CN1039878C Chewing medicinal piece of Shiquandabu wan and preparation thereof
09/22/1998USRE35903 Slow-release preparation of diltiazem, and a medicine provided thereby
09/22/1998US5811568 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
09/22/1998US5811537 Antisense oligonucleotides targeted against human immunodeficiency virus
09/22/1998US5811521 Reacting hemoglobin with crosslinker to form a conjugate having plurality of free functional groups which can further react with a biomolecules such as amino acids, nucleic acids, hormones, co-enzymes, drugs, saccharides and lipids
09/22/1998US5811510 Biodegradable polyacetal polymers and methods for their formation and use
09/22/1998US5811465 Alcohols, amine salts as drug delivery permeation enhancers
09/22/1998US5811454 3-fluorobenzamides with nitrogen mustard groups; anticarcinogenic agents
09/22/1998US5811447 Therapeutic inhibitor of vascular smooth muscle cells
09/22/1998US5811436 Complexed with amberlite irp-88; administering to treat or prevent mixed anxiety and depression
09/22/1998US5811417 Forming aqueous suspension of prednisolone in polyacrylic acid or polyacrylate, transforming into gel
09/22/1998US5811410 Nonsteroidal antiinflammatory drugs
09/22/1998US5811409 Treatment of cholera
09/22/1998US5811406 Stabilized by adding cryoprotectant and lyophilizing; delivering to cell tissue
09/22/1998US5811388 Delivery of drugs to the lower GI tract
09/22/1998US5811387 Enzyme resistant oligo- or poly-peptoid which may selectively bind to polypeptide or effector molecule; mimetics, peptoid libraries
09/22/1998US5811265 Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
09/22/1998US5811131 Tasteless forms of basic drugs prepared by adsorption in situ
09/22/1998US5811130 Danofloxacin, magnesium compound. zinc compound, antioxidant,co-solvent
09/22/1998US5811126 Mixtures of alginates, water-swellable macromolecules, edible hydrocarbon derivatives, divalent metal salts to crosslink the alginates and therapeutically active materials
09/22/1998US5811123 Method of treating mucosal tissue
09/22/1998US5811117 Percutaneously absorbable preparation containing cohesive strength improving agent
09/22/1998US5811115 Composition for treating abnormal conditions of the epithelium of bodily orifices
09/22/1998US5811114 Stabilized hinokitiol and compositions containing same
09/22/1998US5811100 Hyaluronidase covalently coupled to immunostimulating carrier
09/22/1998US5811098 Antibodies to HER4, human receptor tyrosine kinase
09/22/1998US5811096 Comprises urate oxidase and poloxamer in buffered aqueous medium